Series E funding round for Inflammatix raising $57M in September 2024
Series E funding round for Inflammatix raising $57M in September 2024
| Investor | Firm Type | Partner |
|---|
Khosla VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$192.7M
Top Valuation
-
Inflammatix raised $57M in a Series E round.
The round was announced on 09/01/24.
The round was led by Khosla Ventures.